Comparison of Fasting Blood Glucose Measurements From Fingertip and Intravenous on Patient Satisfaction in Patients With Diabetes Mellitus
NCT ID: NCT05976191
Last Updated: 2023-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
110 participants
INTERVENTIONAL
2023-03-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Glucose Measurement in Terms Ofg Pain and Result Consistency
NCT05668702
Effects of Different Methods Used to Take Blood Samples on Blood Glucose Measurements
NCT04486183
Comparison of Blood Glucose Measurement Values
NCT05848362
Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus
NCT04847219
The Influence of Sampling Site When Assessing Glucose Tolerance or Insulin Sensitivity With Oral Glucose Ingestion
NCT02852044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group
Patients whose blood glucose is measured intravenously and from the fingertip
Patients whose blood glucose is measured intravenously and from the fingertip
A satisfaction survey will be conducted after these patients have previously examined their blood glucose via intravenous route, then fingertip blood glucose will be measured and a satisfaction survey will be applied.
control group
Patients with fingertip blood glucose measurement
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients whose blood glucose is measured intravenously and from the fingertip
A satisfaction survey will be conducted after these patients have previously examined their blood glucose via intravenous route, then fingertip blood glucose will be measured and a satisfaction survey will be applied.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No advanced hearing and vision problems
* Able to speak and understand Turkish
* Easy to communicate
* literate
* Agreeing to participate in the research voluntarily
* Patients who are hospitalized
* Regular finger blood sugar monitoring,
* Patients with an intravenous vascular access date within the first 24 hours
* Patients who had been diagnosed with Type 2 Diabetes Mellitus for at least one year were.
Exclusion Criteria
* Patients using antipsychotic medication
* Patients with continuous drug infusion through the intravenous line
* Patients whose intravenous vascular access date has passed 24 hours
* Patients in unconscious, confused, apathetic state
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AYSEGUL
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University-Cerrahpaşa (IUC)
Istanbul, Şişli, Turkey (Türkiye)
Istanbul University-Cerrahpaşa (IUC)
Istanbul, Şişli, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/476
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.